Fusobacterium varium

Information

Microbe Identification

Fusobacterium varium

Microbe id: PMDBM2020730
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Fusobacterium varium [856]
Taxonomy Genus: Fusobacterium [848]
Taxonomy Family: Fusobacteriaceae [203492]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Fusobacterium varium

Identified MGC Region
(click for details)
MGC Cluster (Most Similar) Similarity Compound metabolized by the MGC Type of MGC Reference(PubMed ID)
Unclassified gene clustern.a.Others HGD unassignedPMID: 36782070
Unclassified gene clustern.a.Flavoenzyme lipids catabolismPMID: 36782070
Aminobutyrate to butyrate C. pasteurianumAminobutyrateAminobutyrate to ButyratePMID: 27994578
Ethanolamine degradation S. typhimuriumEthanolamineEUT pathwayPMID: 20234377
Propanediol degradation S. entericaGlycerol / ethanolaminePduPMID: 27242734 / PMID: 20234377
PorA C. sporogenesCholine/proline/tryptophan/Tyr/Phe/leucine/valinePorAPMID: 31831639
Histidine to glutamate K. pneumoniaeHistidineHistidine to glutamate hutHGIU operonPMID: 22933560
Lysine degradation C. sticklandiiLysineLysine degradationPMID: 26620920
Glutamate to butyrate C. symbiosumGlutamate / energy-capturing-relatedGlutamate to butyric,Rnf complexPMID: 27994578 / PMID: 23269825
Pyruvate to acetate-formate E. coliPyruvatePyruvate to acetate-formatePMID: 20622067

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Fusobacterium varium


Identified BGC Region
(click for details)
BGC Cluster (Most Similar) Similarity Compound Synthesized by the BGC Type of BGC Reference (PubMed ID)
Unclassified gene clustern.a.RiPP-likePMID: 34019648
Unclassified gene clustern.a.NRPS-likePMID: 34019648

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Fusobacterium varium distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Fusobacterium varium in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Fusobacterium varium

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJNA449784🔗3.28391531479625mNGS
Hypertension PRJNA509999🔗3.70617077310902mNGS
Diabetes Mellitus, Type 2 PRJDB5860🔗3.4732725455932916S
Diabetes Mellitus, Type 2 PRJNA719138🔗4.1928925110945216S
Liver Cirrhosis, Alcoholic PRJNA690835🔗4.6093589865710816S
Colorectal Neoplasms PRJNA731589🔗2.57311127705364mNGS
Colorectal Neoplasms PRJNA961076🔗3.28417832757692mNGS
Colorectal Neoplasms PRJNA888860🔗3.32428327804664mNGS
Colorectal Neoplasms PRJNA763023🔗3.44497656194213mNGS
Colorectal Neoplasms PRJNA1138893🔗3.54522117873086mNGS
Colorectal Neoplasms PRJEB53415🔗3.6622106537709716S
Colorectal Neoplasms PRJNA731589🔗3.76302636989543mNGS
Colorectal Neoplasms PRJNA284542🔗3.8857843090676716S
Colorectal Neoplasms PRJNA824020🔗3.8924634177463716S
Colorectal Neoplasms PRJNA1126038🔗4.0483978697562116S
Colorectal Neoplasms PRJNA1167935🔗4.18500708462347mNGS
Colorectal Neoplasms PRJNA464414🔗4.4091286243088416S
Colorectal Neoplasms PRJDB11845🔗4.4345486439064416S
Colorectal Neoplasms PRJEB46665🔗4.5636069435476616S
Colorectal Neoplasms PRJNA986175🔗4.8854024766042616S
Tuberculosis, Gastrointestinal PRJNA743795🔗4.8975500357380916S
Parkinson Disease PRJNA588035🔗-2.7574175623713mNGS
Parkinson Disease PRJEB53403🔗2.11580324515951mNGS
Spinal Cord Injuries PRJNA861246🔗4.2563766592858216S
Carcinoma, Hepatocellular PRJNA872871🔗3.8950137850108616S
Celiac Disease PRJNA890948🔗3.1743068362727216S
Hepatolenticular Degeneration PRJNA1038771🔗-4.4961115602980116S
Osteoporosis PRJNA565497🔗2.9406369466903416S
Lymphoma, Large B-Cell, Diffuse PRJNA906033🔗-4.2112998368667416S
Non-alcoholic Fatty Liver Disease PRJNA851946🔗4.1832804969682316S
Crohn Disease PRJNA398089🔗2.92416120396453mNGS
Crohn Disease PRJNA993675🔗3.24856589744954mNGS
Crohn Disease PRJNA938107🔗3.3935996900008116S
Crohn Disease PRJNA1156939🔗3.5575466554048516S
Crohn Disease PRJNA813736🔗3.80114258374769mNGS
Crohn Disease PRJNA917086🔗3.9816972001176216S
Crohn Disease PRJNA793776🔗4.19459976842682mNGS
Crohn Disease PRJNA429990🔗4.35197976739177mNGS
Crohn Disease PRJNA793776🔗4.54462847235774mNGS
Polycystic Ovary Syndrome PRJEB38647🔗3.9978376433642316S
Cholestasis PRJNA478781🔗3.0446819549454516S
Moyamoya Disease PRJNA917033🔗4.0678025131396916S
Multiple System Atrophy PRJNA532538🔗-2.48039789305985mNGS
Dermatitis, Atopic PRJEB45443🔗2.11663859608761mNGS
Anorexia PRJNA674716🔗3.59267010896783mNGS
Cholangiocarcinoma PRJNA932948🔗3.92060835474401mNGS
Anorexia Nervosa PRJEB38930🔗-2.9051472376869116S
Hepatitis C PRJNA1070593🔗4.4177379770347316S
Digestive System Diseases PRJNA438404🔗4.3953212430830716S
Clostridium Infections PRJNA648321🔗2.19053907836856mNGS
Liver Cirrhosis PRJNA861246🔗-4.2078041227636316S
Cystic Fibrosis PRJNA314903🔗2.56916385489424mNGS
Obesity PRJNA1125836🔗3.33072263652627mNGS
HIV Infections PRJNA518910🔗3.9293341580889816S
HIV Infections PRJNA836336🔗4.21436529559098mNGS
Autism Spectrum Disorder PRJNA928241🔗3.8818885484703816S
Hand, Foot and Mouth Disease PRJNA1017976🔗3.490263010411916S
Renal Insufficiency, Chronic PRJNA949558🔗-4.0313494629694316S
Renal Insufficiency, Chronic PRJEB65297🔗3.21132942755186mNGS
Fibromyalgia PRJEB80379🔗3.59408631929631mNGS
COVID-19 PRJNA769052🔗-3.2297041719982916S
COVID-19 PRJNA689961🔗3.15910623136171mNGS
COVID-19 PRJDB13214🔗3.37336741897157mNGS
COVID-19 PRJNA689961🔗3.45076752921374mNGS

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Fusobacterium varium



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Fusobacterium varium



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Fusobacterium varium

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
1Fusobacterium_varium_ATCC_27725 Download

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Fusobacterium varium


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Fusobacterium varium



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Fusobacterium varium

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Fusobacterium varium

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Fusobacterium varium

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
1Fusobacterium_varium_ATCC_27725 View

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Fusobacterium varium



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Fusobacterium varium


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Fusobacterium varium


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?